Evidence map›Paper›PMID 41937202›Full record

ArticleMolecular brain2026

Hippocampal transcriptome profiling in a 22q11.2 deletion syndrome mouse model: comparison with human schizophrenia.

Hinano Yonemaru, Takaaki Ozawa, Takatoshi Hikida

Abstract readComparative Study
In one paragraph

Article in Molecular brain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hinano Yonemaru *Laboratory for Advanced Brain Functions, Institute for Protein Research, The University of Osaka, Suita, Osaka, Japan.ORCID 0009-0009-1436-6103
Takaaki Ozawa *Laboratory for Advanced Brain Functions, Institute for Protein Research, The University of Osaka, Suita, Osaka, Japan. takaaki.ozawa@protein.osaka-u.ac.jp.ORCID 0000-0003-3633-7062
Takatoshi HikidaLaboratory for Advanced Brain Functions, Institute for Protein Research, The University of Osaka, Suita, Osaka, Japan. hikida@protein.osaka-u.ac.jp.ORCID 0000-0002-8653-311X

Funding

AMED JP21gm1510006AMED JP22gm6510012JSPS KAKENHI JP22H01105JSPS KAKENHI JP23K24205JSTSPRING JPMJSP2138
6 · The paper itself

Abstract

22q11.2 deletion syndrome (22q11.2DS) confers one of the highest genetic risks for schizophrenia, yet the molecular mechanisms remain incompletely understood. We performed comprehensive RNA sequencing of the dorsal hippocampus in Df1/+ mice, a 22q11.2DS model, integrating behavioral assessment and cross-species comparison with human schizophrenia postmortem data. Df1/+ mice exhibited selective contextual fear memory impairment without gross locomotor deficits. Transcriptomic analysis using integrated over-representation and gene set enrichment approaches revealed upregulation of synaptic signaling pathways, including glutamatergic and GABAergic neurotransmission, alongside downregulation of translational machinery and ribosomal proteins. Top upregulated pathways included "regulation of postsynaptic membrane potential" and "postsynapse organization," featuring glutamatergic receptors, voltage-gated channels, and synaptic adhesion molecules. Downregulated pathways centered on protein synthesis, including cytoplasmic translation and ribosome biogenesis. Cross-species comparison with human schizophrenia hippocampus revealed limited but directionally consistent gene-level overlap, with 21 of 23 shared differentially expressed genes showing concordant regulation. "Regulation of postsynaptic membrane potential" was the pathway significantly enriched across both species and analytical methods, encompassing both excitatory and inhibitory receptor subunits and synaptic regulators. Concordantly downregulated genes spanned glial markers and extracellular matrix components. These findings reveal a molecular signature of enhanced synaptic gene expression coupled with reduced translational capacity and glial support, with cross-species correspondence supporting the model's translational relevance and highlighting excitatory-inhibitory imbalance as a shared mechanism in hippocampal dysfunction underlying schizophrenia.

Indexed as

DiGeorge SyndromeGene Expression ProfilingHippocampusSchizophreniaAnimalsBehavior, AnimalDisease Models, AnimalDown-RegulationFearGene Expression RegulationHumansMaleSignal TransductionSpecies SpecificitySynapsesTranscriptome22q11.2 deletion syndromeCross-species comparisonExcitatory-inhibitory balanceHippocampusSchizophreniaTranscriptomics

Identifiers

PMID41937202
PMCPMC13188264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.